Discovery of the First-in-Class Intestinal Restricted FXR and FABP1 Dual Modulator ZLY28 for the Treatment of Nonalcoholic Fatty Liver Disease.
- Resource Type
- Article
- Source
- Journal of Medicinal Chemistry; 5/11/2023, Vol. 66 Issue 9, p6082-6104, 23p
- Subject
- Language
- ISSN
- 00222623